Dear Colleagues,
Welcome to Volume 4 of Medical Travel & Digital Health News! I am excited to continue bringing you more insightful interviews with trailblazing companies making a difference in the healthcare industry. As we embark on this new chapter, MTDHN remains committed to delivering fresh perspectives and news, inspiring stories and cutting-edge innovations that are shaping the future of healthcare. Stay tuned as we continue to explore the strategies and successes of the organizations driving change and improving lives across the globe.
To kickstart this new issue, we bring you an exciting interview with Andrew Rosen, vice president of Joint Commission International (JCI), discussing JCI’s mission to enhance healthcare quality and safety worldwide through a flexible and high-quality service approach.
And now, please see below for a special message from the Thought Leadership & Innovation Foundation:
Help Us Bring Hope: Support the Future of Age-Related Macular Degeneration (AMD) Care
We are thrilled to announce, “Eyes on the Future: Innovating for Age-Related Macular Degeneration” (AMD), where a first-of-its-kind online portal, and groundbreaking resource designed to revolutionize patient care for AMD will be unveiled.
The Thought Leadership & Innovation Foundation (TLI) and the American Macular Degeneration Foundation (AMDF) have joined forces to reach the millions of people who are affected by AMD and build a resource and information platform which will serve as a trusted source of information, support and most importantly, hope for people at risk of or diagnosed with macular degeneration.
They need your support in making this vital project a reality and reaching their funding goal of $250,000.
We hope you will join MTDHN in donating to support product development, cloud infrastructure costs and product launch of this groundbreaking portal.
Donate here: https://givebutter.com/eyes-on-the-future#donateModal
Donations are tax deductible.
Your donation goes directly toward building this valuable resource.
About AMD
Macular degeneration, also known as age-related macular degeneration (AMD), is a common eye condition that affects the macula, a small area near the center of the retina in the back of the eye. Early AMD often has no symptoms and may not significantly affect vision. It is estimated to affect over 14% of people aged 40 and older and over 30% of people aged 75 and older. Late AMD, which can cause vision loss, is estimated to affect around 1.47% of people aged 40 and older and 5.7% of people aged 75 and older.
About TLI
The Thought Leadership & Innovation Foundation (TLI) is a not-for-profit organization that works at the nexus of science, technology and public health, innovating for superior prevention, treatment and outcomes for those facing life-altering medical diagnoses. TLI helps patients across the country and around the world find better healthcare outcomes.
About AMDF
The American Macular Degeneration Foundation (AMDF) is a patient-centric foundation that supports potentially game-changing AMD research, education and advocacy in order to improve quality of life and treatment outcomes for all of those affected by AMD.
Please stay safe and tell me how you are breaking ground in these growing industries.
Laura Carabello
Executive Editor and Publisher
Medical Travel & Digital Health News
[email protected]
https://twitter.com/MTT_eNews
https://www.facebook.com/MTT.eNews
https://www.linkedin.com/company/medical-travel-today